A.M. Vitals: Lilly Sees a Profit Drop of Up to 20% in 2012
MEwens
Tough Year Ahead For Drug Maker: Lilly said yesterday its profits could fall by as much as 20% this year amid lower projected sales for its antipsychotic drug Zyprexa and general and administrative costs that will be higher than what analysts had estimated, the WSJ reports. Shares in the drug maker closed lower […]